Georgia Research for Women / ID # 759 Trials

Georgia Research for Women / ID # 759	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Investigator

NCT05106751: A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial Folds

Completed

104

Europe

Hyaluronic acid dermal filler

LG Chem

Correction of Nasolabial Folds

09/22

04/23

OPERA-T, NCT05238116 / 2021-004554-32: Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis ( Study)

Recruiting

123

Europe, Canada, US, RoW

PC945, Placebo

Pulmocide Ltd

Refractory IPA

03/26

04/26

TransportNPC, NCT04860960 / 2020-003136-25: Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1

Active, not recruiting

Europe, US, RoW

Hydroxypropyl-beta-cyclodextrin, Trappsol Cyclo, Placebo, 0.5N saline

Cyclo Therapeutics, Inc.

Niemann-Pick Disease, Type C1

06/25

06/26

NCT04979806 / 2019-002768-28: Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Completed

530

Europe, US, RoW

Cefepime-zidebactam (FEP-ZID), Meropenem

Wockhardt, Medpace, Inc.

Complicated Urinary Tract Infection, Acute Pyelonephritis

01/25

Integral-1, NCT05887908 / 2021-001441-12: Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis

Completed

614

Europe

co-administration of cefepime and nacubactam, co-administration of aztreonam and nacubactam, imipenem/cilastatin

Meiji Seika Pharma Co., Ltd., Japan Agency for Medical Research and Development

Complicated Urinary Tract Infection, Acute Pyelonephritis

11/24

Integral-2, NCT05905055 / 2021-001396-16: P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales

Recruiting

150

Japan

co-administration of cefepime and nacubactam, co-administration of aztreonam and nacubactam, BAT

Meiji Seika Pharma Co., Ltd., Japan Agency for Medical Research and Development

Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, Complicated Intra-abdominal Infection

02/25

EAD501, NCT05607615 / 2022-003819-29: A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease

Recruiting

Hydroxypropyl Beta Cyclodextrin, Trappsol Cyclo, Placebo, 0.5N saline

Cyclo Therapeutics, Inc., Cyclo Therapeutics Inc.

Alzheimer's Disease

03/24

NCT06564311: A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)

Recruiting

Europe, US, RoW

Obexelimab, Placebo

Zenas BioPharma (USA), LLC

Relapsing Multiple Sclerosis

08/25

02/26

NCT05113342: Descartes-25 in Relapsed/Refractory Multiple Myeloma

Terminated

US, RoW

Descartes-25, DC-25

Cartesian Therapeutics

Multiple Myeloma, Relapse Multiple Myeloma

05/23

11/24

SER-155-001, NCT04995653: A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT

Completed

Vancomycin Pre-Treatment, Vancomycin Placebo, SER-155, SER-155 Placebo

Seres Therapeutics, Inc., Memorial Sloan Kettering Cancer Center

Allogeneic Hematopoietic Stem Cell Transplantation

07/24

NCT06910657: Phase I Study of IDOV-Immune to Evaluate Safety and Antitumor Activity in Adults With Advanced Solid Tumors

Not yet recruiting

US, RoW

IDOV-Immune (oncolytic vaccinia virus)

ViroMissile, Inc.

Colorectal Cancer, Pancreatic Cancer, Melanoma, Ovarian Cancer, Gastric Cancer, Esophageal Cancer, Hepatocellular Carcinoma, Renal Cell Carcinoma, Breast Cancer, Sarcoma, Bladder Cancer, Lung Cancer, Prostate Cancer, Cervical Cancers, Head and Neck Cancers, Adrenal Gland Tumors

01/27

05/27

NCT04784299: To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face Volume

Completed

N/A

105

Europe

YVOIRE volume plus, Restylane Lyft with Lidocaine

LG Chem

Midface Volume Deficit

04/22

10/22

NCT05646641: Strength Training in Fibromyalgia on Balance, Neuromuscular Performance and Symptoms

Recruiting

N/A

RoW

Strength exercise

University of Beira Interior, Universidade Federal de Pernambuco

Fibromyalgia

12/24

01/25

NCT05314504: Clinical Investigation of YVOIRE Y-Solution 360 for Lip Augmentation in China

Completed

N/A

174

RoW

YVOIRE Y-Solution 360

LG Chem

Lip Augmentation

02/23

02/24

REMOTE-ILD, NCT05662124: ILD: Health Outcomes in Remote Digital Monitoring Versus Usual Care

Active, not recruiting

N/A

139

Europe

Remote monitoring, patientMpower app

Imperial College Healthcare NHS Trust, patientMpower Ltd., Imperial College London, University College, London, Action for Pulmonary Fibrosis

Interstitial Lung Disease

03/25

04/25

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Investigator

Completed

104

Europe

Hyaluronic acid dermal filler

LG Chem

Correction of Nasolabial Folds

09/22

04/23

Recruiting

123

Europe, Canada, US, RoW

PC945, Placebo

Pulmocide Ltd

Refractory IPA

03/26

04/26

TransportNPC, NCT04860960 / 2020-003136-25: Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1

Active, not recruiting

Europe, US, RoW

Hydroxypropyl-beta-cyclodextrin, Trappsol Cyclo, Placebo, 0.5N saline

Cyclo Therapeutics, Inc.

Niemann-Pick Disease, Type C1

06/25

06/26

NCT04979806 / 2019-002768-28: Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Completed

530

Europe, US, RoW

Cefepime-zidebactam (FEP-ZID), Meropenem

Wockhardt, Medpace, Inc.

Complicated Urinary Tract Infection, Acute Pyelonephritis

01/25

Completed

614

Europe

co-administration of cefepime and nacubactam, co-administration of aztreonam and nacubactam, imipenem/cilastatin

Meiji Seika Pharma Co., Ltd., Japan Agency for Medical Research and Development

Complicated Urinary Tract Infection, Acute Pyelonephritis

11/24

Recruiting

150

Japan

co-administration of cefepime and nacubactam, co-administration of aztreonam and nacubactam, BAT

Meiji Seika Pharma Co., Ltd., Japan Agency for Medical Research and Development

Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, Complicated Intra-abdominal Infection

02/25

EAD501, NCT05607615 / 2022-003819-29: A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease

Recruiting

Hydroxypropyl Beta Cyclodextrin, Trappsol Cyclo, Placebo, 0.5N saline

Cyclo Therapeutics, Inc., Cyclo Therapeutics Inc.

Alzheimer's Disease

03/24

NCT06564311: A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)

Recruiting

Europe, US, RoW

Obexelimab, Placebo

Zenas BioPharma (USA), LLC

Relapsing Multiple Sclerosis

08/25

02/26

NCT05113342: Descartes-25 in Relapsed/Refractory Multiple Myeloma

Terminated

US, RoW

Descartes-25, DC-25

Cartesian Therapeutics

Multiple Myeloma, Relapse Multiple Myeloma

05/23

11/24

SER-155-001, NCT04995653: A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT

Completed

Vancomycin Pre-Treatment, Vancomycin Placebo, SER-155, SER-155 Placebo

Seres Therapeutics, Inc., Memorial Sloan Kettering Cancer Center

Allogeneic Hematopoietic Stem Cell Transplantation

07/24

NCT06910657: Phase I Study of IDOV-Immune to Evaluate Safety and Antitumor Activity in Adults With Advanced Solid Tumors

Not yet recruiting

US, RoW

IDOV-Immune (oncolytic vaccinia virus)

ViroMissile, Inc.

01/27

05/27

NCT04784299: To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face Volume

Completed

N/A

105

Europe

YVOIRE volume plus, Restylane Lyft with Lidocaine

LG Chem

Midface Volume Deficit

04/22

10/22

NCT05646641: Strength Training in Fibromyalgia on Balance, Neuromuscular Performance and Symptoms

Recruiting

N/A

RoW

Strength exercise

University of Beira Interior, Universidade Federal de Pernambuco

Fibromyalgia

12/24

01/25

NCT05314504: Clinical Investigation of YVOIRE Y-Solution 360 for Lip Augmentation in China

Completed

N/A

174

RoW

YVOIRE Y-Solution 360

LG Chem

Lip Augmentation

02/23

02/24

REMOTE-ILD, NCT05662124: ILD: Health Outcomes in Remote Digital Monitoring Versus Usual Care

Active, not recruiting

N/A

139

Europe

Remote monitoring, patientMpower app

Imperial College Healthcare NHS Trust, patientMpower Ltd., Imperial College London, University College, London, Action for Pulmonary Fibrosis

Interstitial Lung Disease

03/25

04/25



	Diseases Companies Products Productz Mechanisms of Action Sites